| 000 | 01115 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250512105131.0 | ||
| 264 | 0 | _c19750117 | |
| 008 | 197501s 0 0 eng d | ||
| 022 | _a0009-9236 | ||
| 024 | 7 |
_a10.1002/cpt1974165part2884 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAzarnoff, D L | |
| 245 | 0 | 0 |
_aPharmacokinetics of methotrexate. _h[electronic resource] |
| 260 |
_bClinical pharmacology and therapeutics _cNov 1974 |
||
| 300 |
_a884-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Topical |
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aChromatography, DEAE-Cellulose |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aLethal Dose 50 |
| 650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
| 650 | 0 | 4 |
_aSkin _xcytology |
| 650 | 0 | 4 | _aTritium |
| 700 | 1 | _aWan, S H | |
| 700 | 1 | _aHuffman, D H | |
| 773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 16 _gno. 5 Part 2 _gp. 884-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/cpt1974165part2884 _zAvailable from publisher's website |
| 999 |
_c4426654 _d4426654 |
||